Skip to content

Role of telomerase enzyme in depression

Activity of telomerase enzyme in major depressive disorder - TED

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/025748
Enrollment
70
Registered
2020-06-09
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F329- Major depressive disorder, singleepisode, unspecified

Interventions

Intervention1: Escitalopram: Single arm. Patient will be prescribed escitalopram 10 mg per day which will be given by oral route. However, if patient could not tolerate the starting dose, then it will

Sponsors

Government Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Diagnosis of Major depressive disorder according to DSM-5 2)Hamilton depression Rating Scale score more than 7 3)Treatment naive patients or Recurrent depressive disorder patients who are off medications for at least last two weeks and current HAM-D score is more than 7

Exclusion criteria

Exclusion criteria: 1)Patient having acute infections and chronic diseases(e.g. cancer, HIV, diabetes, cardiovascular disease or stroke,etc.),which has any association or impact on telomerase activity. 2)Substance Dependence(excluding nicotine and caffeine) in past six months. 3)Pregnant or breast feeding females 4)Actively suicidal patients 5)Major depressive disorder with psychotic features according to DSM-5 6)Patients having hypersensitivity to Escitalopram in the past or any history of adverse reaction with drug in the past

Design outcomes

Primary

MeasureTime frame
1)To assess and compare activity of telomerase enzyme between patients of depression and healthy controls. 2)To study the association of telomerase enzyme activity with severity of depression and treatment response. Timepoint: Baseline,2nd week,4th week,6th week,8th week

Secondary

MeasureTime frame
To see the response on HAM-DTimepoint: Baseline,2nd week,4th week,6th week,8th week

Countries

India

Contacts

Public ContactDr Ajeet Sidana

Government Medical College and Hospital Sector 32 Chandigarh

ajeetsidana@hotmail.com7973235319

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026